Zhan Hangjun 4
4 · Kindred Biosciences, Inc. · Filed Jan 20, 2021
Insider Transaction Report
Form 4
Zhan Hangjun
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-17+6,250→ 43,211 total - Tax Payment
Common Stock
2021-01-17$4.95/sh−3,385$16,756→ 39,826 total - Award
Stock Option (right to buy)
2021-01-20+83,500→ 83,500 totalExercise: $4.44Exp: 2031-01-19→ Common Stock (83,500 underlying) - Exercise/Conversion
Restricted Stock Units
2021-01-17−6,250→ 18,750 total→ Common Stock (6,250 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares are being surrendered to satisfy a tax withholding obligation of the reporting person.
- [F3]On January 17, 2020, the reporting person was granted 25,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- [F4]The option will vest as to 25% after one year following the date of grant, and the remainder will vest in 36 equal monthly installments over the following three years.